Table 4.
HR | 95% CI | p | |
---|---|---|---|
ΔSMI%* during neoadj. (>median vs. <median) | -0.609 | 0.297–0.997 | 0.049 |
N stage (per level) | 0.486 | 0.940–2.801 | 0.082 |
T stage (per level) | 0.496 | 0.993–2.892 | 0.086 |
CCI** (per level) | 0.175 | 0.973–1.459 | 0.091 |
*The percentual change in skeletal muscle index during neoadjuvant treatments
**Charlson comorbidity index